Home › Biotechnology › Genomics
Genomics Market Research Reports & Consulting
The reports in this category analyze and forecast the revenues of the global genetic testing market and its various segments, such as predictive medicine and pharmacogenomic testing. These reports also cover the genomics technology markets for genotyping, multiplexing, real time polymerase chain reaction, and single nucleotide polymorphisms. The reports analyze the global genomics market by region (North America, Europe, Asia, and ROW), and by treatment (including but not limited to Alzheimer’s disease, breast and ovarian cancer, neurofibromatosis, and polycystic kidney disease).
Market Reports
| Title | Published | Price | TOC Available |
|---|---|---|---|
Global DNA and Gene Chip (Microarrays) Market (2010 – 2015)The Global DNA & Gene Chip (microarray) market was valued at $760 million in 2010 and is expected to reach $1,425.2 million by 2015 growing at a CAGR of and 13.4%. The oDNA segment accounted for the largest share – 98% – of the global DNA & gene chip market in 2010. |
May 2011 | $ 4650 |
|
Recombinant Therapies- Advanced Technologies And Global Market (2010 - 2015)The report tracks the market for new and emerging recombinant products, including interferons, erythropoietin, vaccines etc. It gives a detailed analysis of the key players in this market, as well as of the patents and trends in the designer therapeutics industry. Over a 100 market data tables profile the engineered products. |
March 2012 | $ 4650 | |
Protein Microarrays Market (2011-2016)A protein microarray is a platform for gathering proteins by immobilizing prospective binding partners on a firm plane, followed by recognition and detection of the bound protein. Protein microarrays help scientists study protein interactions and expressions for the development of new diagnostic and therapeutic applications. Expressional, functional, and reverse arrays are the three main types of protein microarrays. Protein Microarrays market is expected to register a growth rate of 19.9% between 2010 and 2015. This market is driven by the advances in the fields of genomics and proteomics and improvements in the field of recombinant proteins. |
March 2012 | $ 4650 |